康日百奥生物科技(苏州)有限公司

BioWorkshops (Suzhou) Limited is a biopharmaceutical company headquartered in Hong Kong, developing first-in-class and best-in-class antibody products for global markets in collaboration with international partners. We develop and manufacture clinical drug substances and drug products using cell culture technology. Our headquarters is in Hong Kong, and our first facility is located in Suzhou. Our mission is to consistently develop and achieve approval of biologic products through expert application of manufacturing science.

The company acquired a 28,000 square meter building in Suzhou and has invested more than 300 million RMB to construct state-of-the-art development and clinical manufacturing facilities. Operations began in 2019, and we are working toward obtaining our first biologic IND approval in 2021.